Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease

Neuroscience Letters

Volumn 516, Issue 2, 2012, Pages 232-236

  Han, Yangtong ^a,b,c   Jia, Jianping ^a,b   Jia, Xiang Fei ^d   Qin, Wei ^b   Wang, Suying ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Beijing Jishuitan Hospital   (China)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Alzheimer's disease; Amyloid; Antichymotrypsin; Combination analysis; Plasma

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42];

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEURODEGENERATIVE DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 84860469644     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.094     Document Type: Article

References (18)

1. Abraham C.R., Selkoe D.J., Potter H. Immunochemical identifi{ligature}cation of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988, 52:487-501.
2. Blennow K., deLeon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
3. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. Journal of Neuroscience 2001, 21:372-381.
4. Le Bastard N., Leurs J., Blomme W., De Deyn P.P., Engelborghs S. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients. Journal of Alzheimer's Disease 2010, 21:291-301.
5. Lewczuk P., Kornhuber J., Vanmechelen E., Peters O., Heuser I., Maier W., Jessen F., Bürger K., Hampel H., Frölich L., Henn F., Falkai P., Rüther E., Jahn H., Luckhaus Ch., Perneczky R., Schmidtke K., Schröder J., Kessler H., Pantel J., Gertz H.J., Vanderstichele H., de Meyer G., Shapiro F., Wolf S., Bibl M., Wiltfang J. Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing. Experimental Neurology 2010, 223:366-370.
6. Licastro F., Parnetti L., Morini M.C., Davis L.J., Cucinotta D., Gaiti A., Senin U. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Disease and Associated Disorders 1995, 9:112-118.
7. Lui J.K., Laws S.M., Li Q.X., Villemagne V.L., Ames D., Brown B., Bush A.I., De Ruyck K., Dromey J., Ellis K.A., Faux N.G., Foster J., Fowler C., Gupta V., Hudson P., Laughton K., Masters C.L., Pertile K., Rembach A., Rimajova M., Rodrigues M., Rowe C.C., Rumble R., Szoeke C., Taddei K., Taddei T., Trounson B., Ward V., Martins R.N. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. Journal of Alzheimer's Disease 2010, 20:1233-1242. AIBL Research Group.
8. Ma J., Yee A., Brewer H.B, Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 1994, 372:92-94.
9. Mehta P.D., Pirttilä T., Mehta S.P., Sersen E.A., Aisen P.S., Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Archives of Neurology 2000, 57:100-105.
10. O'Bryant S.E., Xiao G., Barber R., Reisch J., Doody R., Fairchild T., Adams P., Waring S., Diaz-Arrastia R. Texas Alzheimer's Research Consortium. A serum protein-based algorithm for the detection of Alzheimer disease. Archives of Neurology 2010, 67:1077-1081.
11. Padmanabhan J., Levy M., Dickson D.W., Potter H. Alpha 1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain 2006, 129:3020-3034.
12. Pesaresi M., Lovati C., Bertora P., Mailland E., Galimberti D., Scarpini E., Quadri P., Forloni G., Mariani C. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging 2006, 27:904-905.
13. Porcellini E., Davis E.J., Chiappelli M., Ianni E., Di Stefano G., Forti P., Ravaglia G., Licastro F. Elevated plasma levels of α-1-Anti-Chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target. Current Pharmaceutical Design 2008, 14:2659-2664.
14. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., Kaye J.A., Leszek J., Miller B.L., Minthon L., Quinn J.F., Rabinovici G.D., Robinson W.H., Sabbagh M.N., So Y.T., Sparks D.L., Tabaton M., Tinklenberg J., Yesavage J.A., Tibshirani R., Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature Medicine 2007, 13:1359-1362.
15. Roher A.E., Palmer K.C., Yurewicz E.C., Ball M.J., Greenberg B.D. Morphological and biochemical analyses of amyloid plaque core proteins purifi{ligature}ed from Alzheimer disease brain tissue. Journal of Neurochemistry 1993, 61:1916-1926.
16. Sedaghat F., Dedousi E., Costa V., Dimitriadis A.S., Baloyannis S.J. Plasma levels of amyloid beta 1-42 are independent of neuronal function in Alzheimer's disease. Journal of Alzheimer's Disease 2009, 17:343-348.
17. Teunissen C.E., Lütjohann D., von Bergmann K., Verhey F., Vreeling F., Wauters A., Bosmans E., Bosma H., van Boxtel M.P., Maes M., Delanghe J., Blom H.J., Verbeek M.M., Rieckmann P., De Bruijn C., Steinbusch H.W., de Vente J. Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiology of Aging 2003, 24:893-902.
18. Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease. Neurobiology of Aging 1998, 19:109-116. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.